Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Selenium

What does the research say about Selenium?

3 health outcomes synthesised

Selenium research examines selenium primarily for its role in thyroid health, focusing on three outcomes related to autoimmune thyroid conditions. The strongest evidence, supported by 5 studies, shows selenium supplementation consistently reduces thyroid peroxidase antibody (TPOAb) levels in patients with Hashimoto thyroiditis and Graves-Basedow disease, with moderate-to-large effects observed over 3–6 months. Doses studied typically center around 200 μg per day, though effective dose ranges vary across outcomes and populations.

Strongest evidence

Reduced Thyroid Peroxidase Antibody Level (high evidence strength): 4 of 5 studies found beneficial effects, with two large meta-analyses reporting statistically significant moderate-to-large reductions (SMD -0.46 to -0.96). Effects were seen in patients with Hashimoto thyroiditis or Graves-Basedow disease over 3–6 months. The single neutral study combined selenium with Myo-inositol in euthyroid patients, suggesting possible subgroup differences. Increased Serum Free Thyroxine Levels (moderate evidence): 2 of 3 studies reported small beneficial effects, with 200 μg/day as the typical dose, observed at 8–12 weeks in autoimmune thyroid disease populations. One neutral result came from hemodialysis patients, indicating the benefit may not generalize.

Mixed or weaker evidence

Reduced Thyroglobulin Antibody Level (low evidence): 2 of 4 studies showed beneficial effects (one moderate, one small), while 2 found neutral effects. Two large meta-analyses reached opposite conclusions — one showed a transient reduction at 3 months that was not sustained at 6 months, and another found no significant change. The evidence is mixed, with no consistent dose or effect size. Most data come from Hashimoto thyroiditis patients; generalizability beyond that group is unclear.

Effective dose patterns

For thyroid antibody reduction, effective dosing clusters around 200 μg/day, though the high-evidence synthesis for TPOAb did not specify a single effective dose due to variation across studies. The moderate-evidence synthesis for free thyroxine also converges on 200 μg/day. No consistent dose emerged for thyroglobulin antibody reduction.

Population insights

The research population is almost entirely limited to people with autoimmune thyroid conditions — Hashimoto thyroiditis and Graves-Basedow disease. One study in hemodialysis patients found neutral results, suggesting selenium's effects on thyroid outcomes may not extend to non-autoimmune or chronically ill populations. No data were available for selenium-replete healthy individuals or for populations with other thyroid disorders.

Notable caveats

  • Publication bias is a concern for the strongest evidence area: null-result studies may be underrepresented.
  • The form of selenium was unspecified in most studies, limiting conclusions about which form is most effective.
  • Study durations are relatively short (median 6 months for TPOAb), so long-term effects are unknown.
  • Confounding from co-supplementation (e.g., Myo-inositol) occurred in at least one study, complicating interpretation for specific outcomes.

Frequently asked

  • What is Selenium good for according to research?
    Research focuses on selenium's role in autoimmune thyroid health. The strongest evidence — from 5 studies — shows it reduces thyroid peroxidase antibody (TPOAb) levels, with moderate-to-large effects in people with Hashimoto thyroiditis or Graves-Basedow disease. Moderate evidence also suggests small increases in free thyroxine levels, while evidence for reducing thyroglobulin antibodies is mixed and less consistent.
  • What dose of Selenium is typically used in studies?
    For thyroid outcomes, the most frequently studied dose is 200 μg per day, particularly for increasing free thyroxine levels. For TPOAb reduction, effective doses varied across studies, and no single dose range was identified as optimal. The form of selenium used was typically not specified in the underlying research.
  • Who benefits most from Selenium?
    The populations studied almost exclusively have autoimmune thyroid conditions — primarily Hashimoto thyroiditis and Graves-Basedow disease. Benefit for TPOAb reduction was clearest in these groups. A neutral result in hemodialysis patients suggests that people without autoimmune thyroid disease or those with chronic kidney disease may not experience the same effects.
  • Does Selenium help with thyroid peroxidase antibodies?
    Yes, this is the outcome with the strongest evidence. Four of 5 studies reported beneficial reductions in TPOAb, with two large meta-analyses showing moderate-to-large effect sizes (SMD -0.46 to -0.96). Effects were seen over 3 to 6 months in patients with Hashimoto thyroiditis or Graves-Basedow disease. One neutral finding involved co-supplementation with Myo-inositol in euthyroid patients.
  • Are there caveats or limitations in the research on Selenium?
    Yes. The clinical literature on TPOAb reduction is subject to publication bias, meaning null results may be underrepresented. Most studies did not specify the form of selenium used, making it unclear whether selenomethionine, sodium selenite, or other forms differ in effectiveness. Study durations are short (median 6 months or less), and long-term effects are unknown. Effect sizes also varied widely across studies.
  • Does Selenium reduce thyroglobulin antibodies?
    The evidence is mixed and considered low strength. Two of 4 studies reported reductions — one found a moderate effect at 3 months that disappeared by 6 months, while another large meta-analysis found no significant change. Two studies reported neutral findings. No consistent dose or effect size emerged, and most data come from Hashimoto thyroiditis patients.

Most-studied combinations with Selenium

most supplement research is combination research
Also studied with:L-Carnitine (2), Saw Palmetto (2), Blood Orange (2), Vitamin D (3), Vitamin E (2), Vitamin C (2)

  • Grass-Fed

    By Codeage

    4.8 (48 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $44.99
    		In
    Vitacost
    $44.99
    		In
    Vitamin Shoppe
    $44.99
    		In

  • Selenium

    By NOW Foods

    4.8 (15.2K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $12.50
    		In
    iHerb
    $12.24
    		In
    Vitacost
    $11.29
    		In
    Vitamin Shoppe
    $-
    		Out

  • Selenium

    By NOW Foods

    4.9 (43K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $9.79
    		In
    Vitacost
    $9.00
    		In
    Vitamin Shoppe
    $-
    		Out

  • Selenium

    By NOW Foods

    4.8 (15.2K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $8.27
    		In
    iHerb
    $6.72
    		In
    Vitacost
    $6.19
    		In
    Vitamin Shoppe
    $-
    		Out

  • Selenium

    By Protocol for Life Balance

    4.8 (108 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $11.00
    		In
    Vitacost
    $11.00
    		In
    Vitamin Shoppe
    $-
    		Out

  • Animal Parade Gold, Children's Chewable Supplement, Cherry, Grape & Orange

    By NaturesPlus

    4.9 (4.7K reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $15.26
    		In
    Vitacost
    $15.26
    		In
    Vitamin Shoppe
    $16.99
    		In
Back to top